Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

TriSalus Life Sciences (TLSIW) Long-Term Debt Issuances (2022 - 2025)

TriSalus Life Sciences' Long-Term Debt Issuances history spans 4 years, with the latest figure at $10.0 million for Q1 2025.

  • For Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, down 60.0%, while the annual FY2025 figure was $10.0 million, 60.0% down from the prior year.
  • Long-Term Debt Issuances reached $10.0 million in Q1 2025 per TLSIW's latest filing, down from $25.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $25.0 million in Q2 2024 to a low of -$415222.0 in Q2 2023.
  • Average Long-Term Debt Issuances over 4 years is $5.0 million, with a median of $265000.0 recorded in 2022.
  • Peak YoY movement for Long-Term Debt Issuances: crashed 407.57% in 2023, then surged 6120.88% in 2024.
  • A 4-year view of Long-Term Debt Issuances shows it stood at -$360932.0 in 2022, then decreased by 15.04% to -$415222.0 in 2023, then soared by 6120.88% to $25.0 million in 2024, then plummeted by 60.0% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Long-Term Debt Issuances are $10.0 million (Q1 2025), $25.0 million (Q2 2024), and -$415222.0 (Q2 2023).